T Schmeiser
Overview
Explore the profile of T Schmeiser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schneidereit T, Delia D, Schmeiser T, Buehring B
Z Rheumatol
. 2023 Mar;
83(3):210-216.
PMID: 36894623
Background: Day care units are an essential part of psychiatric treatment in Germany. In rheumatology they are also regularly used. Axial spondylarthritis (axSpA) is an inflammatory rheumatic disease that causes...
2.
Schneidereit T, Schmeiser T, Mucke J
Z Rheumatol
. 2022 Sep;
82(4):328-330.
PMID: 36175798
No abstract available.
3.
Hasseli R, Muller-Ladner U, Keil F, Broll M, Dormann A, Frabel C, et al.
Rheumatology (Oxford)
. 2021 Mar;
60(SI):SI51-SI58.
PMID: 33704418
Objectives: To evaluate the influence of the SARS-CoV-2 pandemic on the adherence of patients with inflammatory rheumatic diseases (IRD) to their immunomodulatory medication during the three-month lockdown in Germany. Methods:...
4.
Schmeiser T, Broll M, Dormann A, Frabel C, Hermann W, Hudowenz O, et al.
Z Rheumatol
. 2020 Apr;
79(4):379-384.
PMID: 32303821
The current COVID-19 pandemic inherits an unprecedented challenge for the treating rheumatologists. On the one hand, antirheumatic drugs can increase the risk of infection and potentially deteriorate the course of...
5.
Juche A, Siegert E, Mueller-Ladner U, Riemekasten G, Gunther C, Kotter I, et al.
Z Rheumatol
. 2020 Feb;
79(10):1057-1066.
PMID: 32040755
Background: Raynaud's phenomenon and the frequently ensuing digital ulcerations represent an early and very distressing symptom in patients with systemic sclerosis (scleroderma, SSc) causing significant limitations in the ability to...
6.
Belz D, Moinzadeh P, Riemekasten G, Henes J, Muller-Ladner U, Blank N, et al.
Arthritis Care Res (Hoboken)
. 2019 Jun;
72(8):1041-1048.
PMID: 31150152
Objective: To determine the type and frequency of physical therapy (PT) prescribed by physicians for patients in the registry of the German Network for Systemic Sclerosis. Methods: The data for...
7.
Sluszniak M, Tarner I, Thiele A, Schmeiser T
Z Rheumatol
. 2018 Dec;
78(1):55-65.
PMID: 30552512
Whipple's disease (WD) is a rare, chronic multiorgan disease which can caused by Tropheryma whipplei, a ubiquitous gram positive bacterium. Detection of T. whipplei is mostly performed histologically using periodic...
8.
Schmeiser T, Saar P, Jin D, Noethe M, Muller A, Soydan N, et al.
Rheumatol Int
. 2011 Jul;
32(8):2471-8.
PMID: 21769490
Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disease. Of the numerous organ manifestations, involvement of the upper and lower gastrointestinal tract (GIT) appears to be the most frequent...
9.
Schmeiser T, Muller-Ladner U
Z Rheumatol
. 2010 Jun;
69(7):653-6.
PMID: 20532790
Certolizumab pegol is a new anti-TNF-alpha inhibitor which has been approved for the treatment of rheumatoid arthritis since October 2009. Due to the modification of the antibody fragment by the...
10.
Saar P, Schmeiser T, Tarner I, Muller-Ladner U
Hautarzt
. 2007 Aug;
58(10):844-50.
PMID: 17726594
Systemic sclerosis (SSc) belongs to the family of autoimmune connective tissue diseases and is still a challenge to every practicing physician. The disorder is characterized by progressing fibrosis of the...